A carregar...
Weight-based dosing of enoxaparin for VTE prophylaxis in morbidly obese, medically-Ill patients
INTRODUCTION: In clinical trials, fixed-dose enoxaparin (40 mg once daily) reduces the risk of venous thromboembolism (VTE) in medically-ill patients. However, morbidly obese patients were under-represented in these trials and using fixed-dose enoxaparin in obese patients may be inadequate. We compl...
Na minha lista:
| Main Authors: | , , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
2009
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3245965/ https://ncbi.nlm.nih.gov/pubmed/19272635 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.thromres.2009.02.003 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|